|
Real-time Estimate
Cboe BZX
17:50:45 05/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 6.915 USD | +0.95% |
|
-5.91% | +21.45% |
| 09-16 | Solid Biosciences' Duchenne Muscular Dystrophy Approach, FDA Shift Support Upside, RBC Says | MT |
| 09-16 | RBC Initiates Solid Biosciences at Outperform, Speculative Risk With $18 Price Target | MT |
| Market Cap | 734M 653M 609M 555M 1.05B 70.61B 1.06B 7.37B 2.86B 36.1B 2.76B 2.7B 116B | P/E 2026 * |
-3.95x | P/E 2027 * | -4.08x |
|---|---|---|---|---|---|
| Enterprise Value | 441M 392M 365M 333M 628M 42.37B 634M 4.42B 1.71B 21.66B 1.65B 1.62B 69.51B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 54.8x |
| Free-Float |
88.22% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| SLDB | Delayed | |
CBOE
| SLDB | Real-time |
Last Transcript: Solid Biosciences Inc.
| 1 day | +1.17% | ||
| 1 week | -5.91% | ||
| Current month | -5.26% | ||
| 1 month | -31.02% | ||
| 3 months | -38.12% | ||
| 6 months | -11.50% | ||
| Current year | +21.45% |
| 1 week | 6.78 |  | 7.54 |
| 1 month | 6.78 | | 10.09 |
| Current year | 4.92 | | 11.45 |
| 1 year | 3.79 | | 11.45 |
| 3 years | 1.81 | | 15.05 |
| 5 years | 1.81 | | 37.65 |
| 10 years | 1.81 | | 822.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
Alexander Cumbo
CEO | Chief Executive Officer | 55 | 02/12/2022 |
Annie Ganot
PRN | Corporate Officer/Principal | - | 01/09/2014 |
Kevin Tan
DFI | Director of Finance/CFO | 48 | 09/01/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Ilan Ganot
BRD | Director/Board Member | 52 | 01/03/2013 |
Lynne Sullivan
BRD | Director/Board Member | 60 | 01/11/2015 |
Adam Stone
BRD | Director/Board Member | 46 | 01/11/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 02/07/26 | Exercice | Chairman | 6,880 | 0.0070% | ||
| 10/06/26 | Free | Founder | 77,500 | 0.0787% | ||
| 02/04/26 | Exercice | Chairman | 6,882 | 0.0070% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.80% | -5.91% | +25.00% | +195.26% | 734M | |
| +4.16% | +3.04% | +49.37% | +94.17% | 74.16B | |
| +0.34% | -3.32% | +20.12% | +79.04% | 57.39B | |
| +1.56% | -1.81% | +2.94% | +36.60% | 47.64B | |
| +0.03% | +3.55% | +348.48% | +727.00% | 44.29B | |
| +0.79% | -4.00% | +26.88% | +31.49% | 42.5B | |
| +1.10% | -1.50% | +4.93% | +111.82% | 40.71B | |
| -0.54% | +2.93% | +9.31% | +54.06% | 30.97B | |
| +1.56% | +3.75% | +31.90% | +29.14% | 28.53B | |
| -0.89% | -3.76% | -9.33% | -13.20% | 24.34B | |
| Average | +0.89% | -1.13% | +50.96% | +134.54% | 39.13B | |
| Weighted average by Cap. | +1.21% | -0.85% | +58.08% | +137.20% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 8.6M 7.64M 7.13M 6.5M 12.26M 827M 12.38M 86.34M 33.46M 423M 32.3M 31.6M 1.36B |
| Net income | -226M -200M -187M -171M -322M -21.69B -325M -2.26B -877M -11.09B -847M -829M -35.59B | -243M -215M -201M -183M -346M -23.31B -349M -2.43B -943M -11.92B -911M -891M -38.25B |
| Net Debt | -294M -261M -244M -222M -419M -28.24B -423M -2.95B -1.14B -14.44B -1.1B -1.08B -46.33B | -263M -234M -218M -199M -375M -25.32B -379M -2.64B -1.02B -12.94B -989M -967M -41.54B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/10/26 | $6.840 | -0.15% | 14,973 |
| 02/10/26 | $6.850 | -1.86% | 1,198,189 |
| 01/10/26 | $6.980 | -3.46% | 1,582,201 |
| 30/09/26 | $7.230 | +0.98% | 1,711,185 |
| 29/09/26 | $7.160 | -1.65% | 1,392,322 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SLDB Stock
Select your edition
All financial news and data tailored to specific country editions
